ArticleAmerican journal of clinical and experimental urology2019

Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cells.

Alan P Lombard et al.PubMed ↗Full text ↗

No numbers read from the abstract.